Cargando…
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
BACKGROUND: Pure red cell aplasia (PRCA) is one of the important complications in major ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). The established pathogenic factor of PRCA is the persistence of high anti-donor isohemagglutinins. As previously verified, the condition...
Autores principales: | Zhu, Panpan, Wu, Yibo, Cui, Dawei, Shi, Jimin, Yu, Jian, Zhao, Yanmin, Lai, Xiaoyu, Liu, Lizhen, Xie, Jue, Huang, He, Luo, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873189/ https://www.ncbi.nlm.nih.gov/pubmed/35222414 http://dx.doi.org/10.3389/fimmu.2022.829670 |
Ejemplares similares
-
Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Handisurya, Ammon, et al.
Publicado: (2020) -
Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
por: Asawapanumas, Thiti, et al.
Publicado: (2022) -
Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012) -
Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004) -
ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes
por: Vaezi, Mohammad, et al.
Publicado: (2017)